1-206909778-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005449.5(FCMR):c.932A>T(p.Gln311Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000754 in 1,459,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005449.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCMR | NM_005449.5 | c.932A>T | p.Gln311Leu | missense_variant | 6/8 | ENST00000367091.8 | NP_005440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCMR | ENST00000367091.8 | c.932A>T | p.Gln311Leu | missense_variant | 6/8 | 1 | NM_005449.5 | ENSP00000356058.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000172 AC: 1AN: 58222Hom.: 0 AF XY: 0.0000294 AC XY: 1AN XY: 34058
GnomAD4 exome AF: 0.00000765 AC: 10AN: 1307594Hom.: 0 Cov.: 31 AF XY: 0.00000932 AC XY: 6AN XY: 643554
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2024 | The c.932A>T (p.Q311L) alteration is located in exon 6 (coding exon 6) of the FCMR gene. This alteration results from a A to T substitution at nucleotide position 932, causing the glutamine (Q) at amino acid position 311 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at